B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

P4HB

MOLECULAR TARGET

prolyl 4-hydroxylase subunit beta

UniProt: P07237NCBI Gene: 50345 compounds

P4HB (prolyl 4-hydroxylase subunit beta) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting P4HB

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1isoliquiritigenin4.5089
2isoquercetin4.5089
3galangin4.3073
4juglone hydroxylase [Supplementary Concept] catalyzes1.393
5Equilin0.691

About P4HB as a Drug Target

P4HB (prolyl 4-hydroxylase subunit beta) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented P4HB interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

P4HB inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.